Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs
Authors
Keywords
-
Journal
Journal of Materials Chemistry B
Volume 5, Issue 17, Pages 3132-3144
Publisher
Royal Society of Chemistry (RSC)
Online
2017-03-30
DOI
10.1039/c6tb03366k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization
- (2016) Germán A. Islan et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Characterization of smart auto-degradative hydrogel matrix containing alginate lyase to enhance levofloxacin delivery against bacterial biofilms
- (2015) German A. Islan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and characterization of new enzymatic modified hybrid calcium carbonate microparticles to obtain nano-architectured surfaces for enhanced drug loading
- (2015) G.A. Islan et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Controversies in the Treatment of Early-Stage Hodgkin’s Lymphoma
- (2015) Dan L. Longo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthesis and characterization of CaCO 3 –biopolymer hybrid nanoporous microparticles for controlled release of doxorubicin
- (2014) Valeria E. Bosio et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Pulmonary drug delivery by powder aerosols
- (2014) Michael Yifei Yang et al. JOURNAL OF CONTROLLED RELEASE
- Cystic fibrosis genetics: from molecular understanding to clinical application
- (2014) Garry R. Cutting NATURE REVIEWS GENETICS
- Photodegradation of levofloxacin in aqueous and organic solvents: A kinetic study
- (2013) Iqbal Ahmad et al. ACTA PHARMACEUTICA
- A Functional DNase I Coating to Prevent Adhesion of Bacteria and the Formation of Biofilm
- (2013) Jan J. T. M. Swartjes et al. ADVANCED FUNCTIONAL MATERIALS
- Alginate Lyase and Ciprofloxacin Co-Immobilization on Biopolymeric Microspheres for Cystic Fibrosis Treatment
- (2013) German A. Islan et al. MACROMOLECULAR BIOSCIENCE
- Vibrational analysis, electronic structure and nonlinear optical properties of Levofloxacin by density functional theory
- (2013) Sethu Gunasekaran et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Aerosolised levofloxacin in cystic fibrosis
- (2013) Gerd Döring et al. Expert Opinion on Orphan Drugs
- Inhaled Aztreonam Lysine for Cystic Fibrosis Pulmonary Disease–Related Outcomes
- (2012) Kimberly A Pesaturo et al. ANNALS OF PHARMACOTHERAPY
- Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment ofPseudomonas aeruginosabiofilm infections
- (2012) Oana Ciofu et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
- (2012) Gerd Döring et al. Journal of Cystic Fibrosis
- Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
- (2012) Anders Folkesson et al. NATURE REVIEWS MICROBIOLOGY
- Structural analysis of protein–DNA and protein–RNA interactions by FTIR, UV-visible and CD spectroscopic methods
- (2012) H. A. Tajmir-Riahi et al. SPECTROSCOPY-AN INTERNATIONAL JOURNAL
- Pharmacokinetics and Safety of MP-376 (Levofloxacin Inhalation Solution) in Cystic Fibrosis Subjects
- (2011) David E. Geller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis of hollow vaterite CaCO3 microspheres in supercritical carbon dioxide medium
- (2011) Thomas Beuvier et al. JOURNAL OF MATERIALS CHEMISTRY
- Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery
- (2010) Shohreh Alipour et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- New Aerosol Delivery Devices for Cystic Fibrosis
- (2010) Kenneth C Kesser et al. Respiratory Care
- Development of the First Inhaled Antibiotic for the Treatment of Cystic Fibrosis
- (2010) L. M. Rose et al. Science Translational Medicine
- Size and Shape of Protein Molecules at the Nanometer Level Determined by Sedimentation, Gel Filtration, and Electron Microscopy
- (2009) Harold P. Erickson BIOLOGICAL PROCEDURES ONLINE
- Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa
- (2009) M. Alipour et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Levofloxacin
- (2008) Vanessa R Anderson et al. DRUGS
- A hand-held apparatus for “nose-only” exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages
- (2008) Jatinder Kaur et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins
- (2008) Ana Grenha et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Solid lipid nanoparticles for pulmonary delivery of insulin
- (2008) Jie Liu et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model
- (2008) Moritz Beck-Broichsitter et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules
- (2007) Benjamin A. Teply et al. BIOMATERIALS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started